Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cash per Share : RM0.00 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Malaysian Genomics Resource Centre Bhd Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Malaysian Genomics Resource Centre Bhd's Cash per Share for the quarter that ended in Mar. 2024 was RM0.00.

Malaysian Genomics Resource Centre Bhd Cash per Share Historical Data

The historical data trend for Malaysian Genomics Resource Centre Bhd's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Malaysian Genomics Resource Centre Bhd Cash per Share Chart

Malaysian Genomics Resource Centre Bhd Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Cash per Share

Get a 7-Day Free Trial

0.02

0.06

0.04

0.10

Malaysian Genomics Resource Centre Bhd Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Mar24
Cash per Share	Get a 7-Day Free Trial															0.06	0.03	0.03	0.03	-

Malaysian Genomics Resource Centre Bhd Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Malaysian Genomics Resource Centre Bhd's Cash per Share for the fiscal year that ended in Jun. 2021 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	11.309	/	118.51
	=	0.10

Malaysian Genomics Resource Centre Bhd's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.436	/	137.21
	=	0.00

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Malaysian Genomics Resource Centre Bhd Cash per Share Related Terms

Thank you for viewing the detailed overview of Malaysian Genomics Resource Centre Bhd's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Malaysian Genomics Resource Centre Bhd (XKLS:0155) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

8F, Jalan Teknologi 3/6, Taman Sains, Petaling Jaya, SGR, MYS, 47810

Website

http://www.mgrc.com.my

Malaysian Genomics Resource Centre Bhd is a Malaysia-based company engaged in providing laboratory services. It primarily offers genome sequencing and analysis (GSA) services, genetic screening services (GSS), and pathology services. GSA services involve the sequencing and analysis of the DNA of humans, animals, plants, and microbes, to discover meaningful biological information. The company is engaged in providing GSS by developing its own range of genetic screening tests under the brand Dtect which screen human DNA for genetic markers related to diseases and health conditions. It derives the majority of its revenue from Pathology services.

Malaysian Genomics Resource Centre Bhd (XKLS:0155) Headlines

No Headlines